Smith & Nephew plc (LON:SN – Get Free Report) announced a dividend on Thursday, August 1st, Upcoming.Co.Uk reports. Stockholders of record on Thursday, October 3rd will be given a dividend of $0.14 per share on Friday, November 8th. This represents a dividend yield of 1%. The ex-dividend date is Thursday, October 3rd. The official announcement can be seen at this link.
Smith & Nephew Stock Up 0.4 %
SN opened at GBX 1,163 ($15.56) on Wednesday. The company has a current ratio of 2.51, a quick ratio of 0.84 and a debt-to-equity ratio of 70.22. The stock has a market cap of £10.14 billion, a PE ratio of 4,473.08, a PEG ratio of 0.47 and a beta of 0.62. The company has a 50 day moving average price of GBX 1,163.12 and a 200 day moving average price of GBX 1,062.64.
Analyst Upgrades and Downgrades
Separately, Berenberg Bank reaffirmed a “buy” rating and set a £145 ($193.95) price objective on shares of Smith & Nephew in a research report on Monday, August 5th. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of GBX 3,956.20 ($52.92).
About Smith & Nephew
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.
Featured Articles
- Five stocks we like better than Smith & Nephew
- 3 Stocks to Consider Buying in October
- Trade Like a Member of Congress With These 2 ETFs
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- October’s Top 3 Stocks Revealed by MarketBeat’s MarketRank Tool
- Stock Splits, Do They Really Impact Investors?
- Chinese Stock Surge: Should You Invest After Stimulus Boost?
Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.